Services for prediction of drug susceptibility for HIV proteases and reverse transcriptases at the HIV drug research centre

SUMMARY The HIV Drug Research Centre (HIVDRC) has established Web services for prediction of drug susceptibility for HIV proteases and reverse transcriptases. The services are based on two proteochemometric models which accepts a protease or reverse transcriptase sequence in amino acid form, and outputs the predicted drug susceptibility values. The predictions are based on a comprehensive analysis where all the relevant inhibitors are included, resulting in models with excellent predictive capabilities. AVAILABILITY AND IMPLEMENTATION The services are implemented as interoperable Web services (REST and XMPP), with supporting web pages to allow for individual analyses. A set of plugins were also developed which make the services available from the Bioclipse workbench for life science. Services are available at http://www.hivdrc.org/services.

[1]  Thomas Lengauer,et al.  Prediction of response to antiretroviral therapy by human experts and by the EuResist data‐driven expert system (the EVE study) , 2010, HIV medicine.

[2]  Tommy F. Liu,et al.  Web resources for HIV type 1 genotypic-resistance test interpretation. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  Carole A. Goble,et al.  BioCatalogue: a universal catalogue of web services for the life sciences , 2010, Nucleic Acids Res..

[4]  Thomas Lengauer,et al.  Geno2pheno: estimating phenotypic drug resistance from HIV-1 genotypes , 2003, Nucleic Acids Res..

[5]  Egon L. Willighagen,et al.  Bioclipse 2: A scriptable integration platform for the life sciences , 2009, BMC Bioinformatics.

[6]  Jarl E. S. Wikberg,et al.  Generalized Proteochemometric Model of Multiple Cytochrome P450 Enzymes and Their Inhibitors , 2008, J. Chem. Inf. Model..

[7]  Ola Spjuth,et al.  Proteochemometric Modeling of the Susceptibility of Mutated Variants of the HIV-1 Virus to Reverse Transcriptase Inhibitors , 2010, PloS one.

[8]  Egon L. Willighagen,et al.  XMPP for cloud computing in bioinformatics supporting discovery and invocation of asynchronous web services , 2009, BMC Bioinformatics.

[9]  Egon L. Willighagen,et al.  Bioclipse: an open source workbench for chemo- and bioinformatics , 2007, BMC Bioinformatics.

[10]  Peteris Prusis,et al.  Unbiased descriptor and parameter selection confirms the potential of proteochemometric modelling , 2005, BMC Bioinformatics.

[11]  Peteris Prusis,et al.  Proteochemometric modeling of HIV protease susceptibility , 2008, BMC Bioinformatics.